SCAPE GROUP LIMITED

Financial Health Assessment: SCAPE GROUP LIMITED

1. Financial Health Score: A (Excellent)

Explanation: The patient is in peak financial condition. Exhibiting robust cash generation, a strongly positive net asset position, and a formidable liquidity ratio, this business shows no immediate signs of financial distress. The only minor check-up required is ensuring that the large cash reserves are being actively put to work rather than sitting idle, and monitoring the growing debtor book to ensure timely collection.

2. Key Vital Signs

Based on the latest filed accounts (Year Ending 31 March 2014)

• Cash Reserves (Blood Pressure): £4,261,872 The company's financial blood pressure is incredibly strong. Cash has surged by approximately 73% from the previous year (£2,468,149), indicating a highly efficient circulatory system where cash is being generated faster than it is being spent.
• Current Ratio (Immune System Strength): 3.97:1 Calculated as Current Assets (£5,860,598) divided by Current Liabilities (£1,475,003). This means the company has nearly £4 of liquid assets for every £1 of short-term debt. It is more than capable of fighting off any immediate financial infections or unexpected shocks.
• Profit Retention (Muscle Growth): +£1,897,740 The Profit and Loss reserve has grown from £618,091 to £2,515,831. This massive leap in retained earnings shows a business that is building significant financial muscle and reinvesting its strength into the core structure of the organization.
• Long-Term Liabilities (Cholesterol Levels): £1,441,000 While total liabilities stand at £2.9M, over half of this is long-term debt. This is akin to manageable, slow-burning cholesterol rather than an immediate blockage. With net current assets of £4.3M, servicing this debt poses no strain on the heart.

3. Diagnosis

Symptoms Analysis: The financial data reveals a business that is exceptionally healthy. As a public-sector owned procurement specialist, SCAPE GROUP LIMITED operates in an environment where stability is key, and the balance sheet reflects this perfectly. The company's "skeleton" (tangible fixed assets) is very light at just £26,272, which is entirely normal for a consultancy and procurement firm—the true value lies in the brain (human capital) rather than the bones (physical assets).

The most prominent symptom is the rapid accumulation of cash and debtors. Debtors have grown from £1.09M to £1.59M. While this indicates strong revenue growth, it is a symptom that requires observation: if debtors continue to swell without converting to cash, it could indicate that public sector clients are taking longer to pay, which could lead to a future cash flow "fever."

Prognosis: The future financial outlook is highly positive. The company is generating substantial organic cash flow, carries zero signs of insolvency, and has a massive safety net of working capital. Assuming the procurement frameworks continue to generate business, the patient is set for sustained excellent health.

4. Recommendations

To maintain this peak physical condition and optimize performance, the following "lifestyle adjustments" are recommended:

1. Cardiovascular Exercise for Idle Cash: With over £4.2M sitting in the bank, the company may be suffering from a slight case of "lazy capital." While having a healthy cash buffer is excellent, excess cash sitting in low-yield accounts can lose value to inflation. Management should consider whether this cash could be better deployed—whether through higher-yield short-term investments, returning a dividend to the public-sector shareholders, or reinvesting into business growth.
2. Monitor the Debtor Pulse: With debtors growing by roughly 46% year-on-year, it is vital to ensure the credit control function remains rigorous. Implement regular "check-ups" on aged debtors to ensure local authorities and contractors are paying within terms, preventing a healthy asset from turning into a bad debt "blood clot."
3. Health Check Frequency: The financial x-ray used for this assessment dates back to 2014. Given the rapid growth exhibited in these statements, it is imperative to ensure more recent filings are reviewed to confirm that this trajectory of excellent health has been maintained in the subsequent years.